| Literature DB >> 33801408 |
Dragos Serban1,2, Bogdan Socea2,3, Simona Andreea Balasescu1, Cristinel Dumitru Badiu2,4, Corneliu Tudor1, Ana Maria Dascalu2, Geta Vancea2, Radu Iulian Spataru2,5, Alexandru Dan Sabau6, Dan Sabau6, Ciprian Tanasescu6.
Abstract
Background andEntities:
Keywords: acute cholecystitis; elderly; laparoscopic cholecystectomy; safety
Year: 2021 PMID: 33801408 PMCID: PMC8002041 DOI: 10.3390/medicina57030230
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Tokyo Guidelines (TG13/TG18) severity risk scale [9,25].
| Grade III (severe) acute cholecystitis | Acute cholecystitis with organ/system (renal, cardiovascular, hepatic, respiratory, neurologic, hematologic) dysfunction |
| Grade II (moderate) acute cholecystitis | Acute cholecystitis associated with: WBC * > 18,000/mmc Palpable tender mass in the right upper abdominal quadrant Marked local inflammation Onset > 72 h |
| Grade I (mild) acute cholecystitis | Acute cholecystitis which does not meet criteria for grade II or III |
* WBC—white blood cells.
Demographic and clinical data of non-operated patients.
| No. | Age | TG 13/18 Severity Form | Reason for Postponed Surgery | Returned for Elective Surgery during the Study Period |
|---|---|---|---|---|
| 1 | 37 | mild | Refused surgery | no |
| 2 | 39 | mild | Associated giant right renal cyst; deferred to urology after conservative management | yes, 4 months later |
| 3 | 53 | moderate | Neglected arterial hypertension * | yes, after one month |
| 4 | 53 | mild | Refused surgery | no |
| 5 | 57 | moderate | Morbid obesity (BMI ** 43) | no |
| 6 | 61 | mild | Ultrasound (US) and Computed tomography (CT) exam raised suspicion of gallbladder carcinoma | yes, for further evaluation and elective oncological surgery |
| 7 | 64 | mild | Morbid obesity (BMI 41) | no |
| 8 | 69 | mild | Refused surgery | yes, 6 months later |
| 9 | 72 | mild | US and CT exam raised suspicion of colon cancer | yes, for further evaluation and elective oncological surgery |
| 10 | 82 | moderate | Increased anesthetic risk due to severe cardiac insufficiency | no |
| 11 | 86 | mild | Refused surgery | no |
* hypertension—Blood pressure (BP) of 22 mmHg at admission. As the patient responded to medical therapy for acute cholecystitis, he was referred to a cardiologist and asked to return for elective surgery, under adequate medication. ** BMI – body mass index.
Figure 1Age distribution of patients with emergency cholecystectomy for acute cholecystitis in the study group (n = 333).
Demographic and preoperative data in the 4 age-subgroups.
| Group | A | B | C | D | Total | |
|---|---|---|---|---|---|---|
| Age (years) | ≤49 | 50–64 | 65–79 | ≥80 | 18–91 | |
| Number | 122 | 111 | 66 | 34 | 333 | |
| Onset > 72 h | 59.8% | 69.4% | 75.8% | 79.4% | 68.2% | |
| Female (%) | 29.5% | 29.7% | 36.4% | 26.5% | 30.6% | |
| Severity forms TG13/TG 18 | ||||||
| Mild | 36.10% | 27% | 22.70% | 11.80% | 27.90% | |
| Moderate | 61.50% | 68.50% | 65.20% | 70.60% | 65.50% | |
| Severe | 2.50% | 4.50% | 12.10% | 17.60% | 6.60% | |
| Leukocytes ≥ 18,000/mmc | 2.5% | 7.2% | 12.1% | 14.7% | 7.2% | |
| Fibrinogen > 400 mg/dL | 34.4% | 48.6% | 60.6% | 67.6% | 47.7% | |
| Creatinine > 1.2 mg/dL | 19% | 19.8% | 37.9% | 50% | 26.2% | |
| Aspartate transaminase (AST), Alanine transaminase (ALT) > 40 UI/L | 33.6% | 38.7% | 28.8% | 47.1% | 35.7% | |
| INR(international normalized ratio) > 2 | 0 | 2.7% | 0 | 5.9% | 1.5% | |
| Bilirubin > 1.2 mg/dL | 11.4% | 9.9% | 24.2% | 29% | 15.31% | |
| Sign of acute cardiac insufficiency at admission *** | 2.5% | 9.9% | 21.2% | 44.1% | 12.9% | |
| Neurologic decompensation at admission | 0 | 0 | 0.015% | 0.029% | 0.006% | N/A |
| ASA PS risk | ||||||
| I | 33.60% | 18% | 6.10% | 0 | 19.50% | |
| II | 54.10% | 57.70% | 53% | 44.10% | 54.10% | |
| III | 12.30% | 20.70% | 37.90% | 44.10% | 23.40% | |
| IV | 0 | 2.70% | 3% | 8.80% | 2.40% | |
| V | 0 | 0.90% | 0 | 2.90% | 0.60% | |
| CCI | ||||||
| 0 | 88.40% | 60.30% | 28.70% | 20.50% | 58.80% | |
| 1 | 5.70% | 14.40% | 27.20% | 26.50% | 15.30% | |
| 2 | 1.60% | 14.10% | 21.20% | 20.60% | 8.40% | |
| 3 | 5.70% | 11.70% | 12.10% | 8.80% | 9.30% | |
| 4 | 1.60% | 3.60% | 4.50% | 14.70% | 5.10% | |
| 5 | 0 | 1.80% | 3% | 0 | 1.20% | |
| ≥6 | 0.80% | 1.80% | 0 | 8.80% | 1.80% |
Footnote: (1) Test of Linear-by-Linear Association; (2) Fisher’s exact test; ASA PS: American Society of Anesthesiologists Physical Status Classification; TG13/18: Tokyo Guidelines classification risk; CCI: Charlson Comorbidity Index. *** described according to Common Guide of diagnostic and treatment of Acute Cardiac Insufficiency of European Society of Intensive Therapy and European Society of Cardiology: (i) Aggravated preexisting cardiac insufficiency (edema of the lower limbs, congestion); (ii) Hypertensive Cardiac insufficiency (high BP, tachycardia, signs of vasoconstriction); (iii) Pulmonary acute edema: acute respiratory disfunction, with tachypnea and orthopnea, SaO2 < 90% before oxygen administration; (iv) Acute coronary syndrome; (v) Cardiogenic shock: hypotension requiring vasopressor medication, signs of organ hypoperfusion, with oliguria.
Figure 2Boxplot representation of age distribution by Tokyo Guidelines TG13/TG18 Classification.
Surgical approach and postoperative outcomes in the 4 subgroups.
| Group | A (<50 Years) | B (50–64 Years) | C (65–79 Years) | D (>80 Years) | Total | |
|---|---|---|---|---|---|---|
| Type of surgery | ||||||
| LC | 119 (97.5%) | 99 (89.2%) | 51 (77.3%) | 26 (76.5%) | 295(88.6%) | |
| Conversion | 2 (1.6%) | 8 (7.2%) | 10 (15.2%) | 6 (17.6%) | 26 (7.8%) | |
| OC | 1 (0.8%) | 4 (3.6%) | 5 (7.6%) | 2 (5.9%) | 12 (3.6%) | |
| Drainage in LC | 8 (6.72%) | 9 (9.09%) | 12 (21.05%) | 9 (34.6%) | 36 (12.2%) | |
| Hospital days (mean ± SD *) | ||||||
| Total | 4.65 ± 3.03 | 6.35 ± 3.03 | 6.53 ± 3.9 | 7.4 ± 4.4 | 6 ± 3.35 | |
| LC | 4.58 ± 2.21 | 5.38 ± 2.7 | 5.83 ± 3.47 | 5.66 ± 2.53 | 5.51 ± 2.9 | |
| Conversion | 6.8 ± 2.77 | 9.2 ± 3.52 | 11.42 ± 4.5 | 12.2 ± 5.01 | 9.92 ± 4.15 | |
| OC | 9 | 9 ± 5.56 | 7.25 ± 3.26 | 10.8 ± 3.6 | 9.15+/4.15 | |
| Postoperative hospital days (mean ± SD) | ||||||
| Total | 3.46 ± 2.27 | 3.75 ± 3.43 | 4.22 ± 3.53 | 5.35 ± 4.1 | 3.63 ± 2.8 | |
| LC | 2.49 ± 1.46 | 2.68 ± 1.7 | 2.75 ± 1.81 | 3.83 ± 1.91 | 3.12 ± 2.22 | |
| Conversion | 5.2 ± 2.77 | 6.72 ± 2.63 | 9.14 ± 4.45 | 10 ± 5.33 | 7.73 ± 3.9 | |
| OC | 6 | 8 ± 3.6 | 5.75 ± 3.77 | 10.8 ± 3.6 | 6.92 ± 2.92 | |
(1) Fisher’s exact test; (2) ANOVA Linearity test; LC: laparoscopic cholecystectomy; OC: open cholecystectomy; Drain insertion was not a routine practice in our clinic for laparoscopic cholecystectomy; * SD—standard deviation.
Postoperative complications according to Clavier-Dindo Classification.
| Clavier-Dindo Classification | A (<50 Years) | B (50–64 Years) | C (65–79 Years) | D (>80 Years) | Total | |
|---|---|---|---|---|---|---|
| I (surgical site infections) | ||||||
| Total | 1 (0.81%) | 3 (3.03%) | 3 (4.53%) | 2 (5.71%) | 5 (3.05%) | |
| LC | 1 (0.8%) | 2 (2%) | 2 (3.92%) | 1 (3.85%) | 6 (2%) | |
| conversion | 0 | 1 (12.5%) | 1 (10%) | 0 | 2(7.6%) | |
| OC | 0 | 0 | 0 | 1 (50%) | 1 (8.3%) | |
| II (surgical related complications, treated pharmacological) | ||||||
| Total | 2(1.6%) | 6 (%) | 5 (%) | 2 (5.8%) | 16 (%) | |
| LC | 1 (0.84%) | 2 (%) | 2 (3.9%) | 1 (3.8%) | 7 (%) | |
| conversion | 0 | 3 (37.5%) | 2 (%) | 1 (16.6%) | 6 (%) | |
| OC | 1 (100%) | 1 (25%) | 1 (20%) | 0 | 3 (25%) | |
| III (surgical related complications requiring endoscopic/surgical/Rx approach) | ||||||
| Total | 0 | 1 (0.9%) | 1(1.5%) | 0 | 2 (0.6%) | |
| LC | 1 (1%) | 0 | 1 (0.33%) | |||
| conversion | 0 | 1 (10%) | 1 (3.84%) | |||
| OC | 0 | 0 | 0 | |||
| IV (requiring intensive care) | ||||||
| Total | 3 (2.4%) | 7 (6.3%) | 5 (7.57%) | 3 (8.8%) | 18 (5.4%) | |
| LC | 1 (0.8%) | 4 (4.04%) | 3 (5.8%) | 2 (7.6%) | 10 (3.36%) | |
| conversion | 1 (50%) | 0 | 1 (10%) | 1 (16.6%) | 3 (11.5%) | |
| OC | 1 (100%) | 3 (75%) | 2 (40%) | 0 | 6 (50%) | |
| V (Deceased) | ||||||
| Total | 1 (0.81%) | 2 (1.8%) | 1 (1.51%) | 0 | 4 (1.2%) | |
| LC | 0 | 1 (1.01%) | 0 | 0 | 0.33% | |
| conversion | 1 (50%) | 1 (12.5%) | 0 | 0 | 8.33% | |
| OC | 0 | 0 | 1 (20%) | 0 | 7.69% | |
(1) Fisher’s exact test; (2) ANOVA Linearity test; LC: laparoscopic cholecystectomy.
Standardized Canonical Discriminant Functions for (LC, OC, Conversion).
| Standardized Canonical Discriminant Function Coefficients | ||
|---|---|---|
| Standardized Function | ||
| F1 | F2 | |
| Age | 0.300 | −0.151 |
| Bilirubin | 0.127 | 0.711 |
| Leukocytes | 0.426 | 0.173 |
| Gangrenous cholecystitis | 0.637 | −0.523 |
| CCI | 0.094 | 0.661 |
Figure 3Patient representation (n = 333) in the space (F1, F2) of Unstandardized Canonical Discriminant Functions between (LC, OC, Conversion). (Specification: functions at Group Centroids are: (−0.203, −0.004) for LC (laparoscopic cholecystectomy); (1.739, −0.964) for OC (open cholecystectomy) and (1.564, 0.508) for Conversion). Wilks’ lambda computed for the two canonical functions are significant (test of the two functions: chi-square (df = 10) 111.08, p < 0.001; test of second function: chi-square (df = 4) = 17.05, p = 0.002). Cross-validation of the model: 81.4% of cross-validated cases are correctly classified. The relative dispersion of patients with conversion to open surgery indicates that other factors, such as surgical experience or particular intraoperative findings, may be involved.
The Fisher’s linear discriminant analysis for cardiovascular severe complications and mortality.
| Standardized Canonical Discriminant Function Coefficients | |
|---|---|
| Function | |
| 1 | |
| Gangrenous cholecystitis | 0.211 |
| Stroke | 0.785 |
| Diabetes | 0.249 |
| Chronic renal insufficiency | 0.264 |
| Fibrinogen > 400 mg/dL | 0.348 |
| Grade III Cholecystitis (TG13/TG18 Severity forms) | 0.163 |